Genomic Vision SA - ESG Rating & Company Profile powered by AI
Other companies in the scoring industry group for Genomic Vision SA are displayedin the table. If you are employed by Genomic Vision SA and you would like to licence your ESG rating, please get in touch. Check the bottom of this webpage for potential risks for Genomic Vision SA based on industry, geography and marketcap.
Genomic Vision SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
217 | Takara Bio Inc | 7.2 | High |
217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
224 | Genomic Vision SA | 7.1 | High |
224 | Celularity Inc | 7.1 | High |
224 | Bilcare Ltd | 7.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Genomic Vision SA have an accelerator or VC vehicle to help deliver innovation?
Does Genomic Vision SA disclose current and historical energy intensity?
Does Genomic Vision SA report the average age of the workforce?
Does Genomic Vision SA reference operational or capital allocation in relation to climate change?
Does Genomic Vision SA disclose its ethnicity pay gap?
Does Genomic Vision SA disclose cybersecurity risks?
Does Genomic Vision SA offer flexible work?
Does Genomic Vision SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Genomic Vision SA disclose the number of employees in R&D functions?
Does Genomic Vision SA conduct supply chain audits?
Does Genomic Vision SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Genomic Vision SA conduct 360 degree staff reviews?
Does Genomic Vision SA disclose the individual responsible for D&I?
Does Genomic Vision SA disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Genomic Vision SA disclose current and / or historical scope 2 emissions?
Does Genomic Vision SA disclose water use targets?
Does Genomic Vision SA have careers partnerships with academic institutions?
Did Genomic Vision SA have a product recall in the last two years?
Does Genomic Vision SA disclose incidents of discrimination?
Does Genomic Vision SA allow for Work Councils/Collective Agreements to be formed?
Has Genomic Vision SA issued a profit warning in the past 24 months?
Does Genomic Vision SA disclose parental leave metrics?
Does Genomic Vision SA disclose climate scenario or pathway analysis?
Does Genomic Vision SA disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Genomic Vision SA disclose the pay ratio of women to men?
Does Genomic Vision SA support suppliers with sustainability related research and development?
Does Genomic Vision SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Genomic Vision SA reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Genomic Vision SA involved in embryonic stem cell research?
Does Genomic Vision SA disclose GHG and Air Emissions intensity?
Does Genomic Vision SA disclose its waste policy?
Does Genomic Vision SA report according to TCFD requirements?
Does Genomic Vision SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Genomic Vision SA disclose energy use targets?
Does Genomic Vision SA disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Genomic Vision SA have a policy relating to cyber security?
Have a different question?
Potential Risks for Genomic Vision SA
These potential risks are based on the size, segment and geographies of the company.
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.